Asthma inhalers tied to large greenhouse gas emissions production
By
Haymarket Media
Sep 04, 2024
Metered-dose inhalers were responsible for almost all inhaler-related emissions.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
Environmental Protection Agency finalizes stronger air quality standards
Feb 09, 2024
The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
Tezepelumab reduces mucus plugs in adults with uncontrolled asthma
Sep 29, 2023
The reduction in mucus plug scores correlates with improvements in lung function and reductions in inflammatory markers.
Review shows certain exercises benefit patients with asthma
Aug 14, 2023
Yoga, breathing control practices and aerobic training show benefits.
FDA approves new two-drug combo medicine for asthma
Jan 12, 2023
The medication is the first approved in the United States to contain an inhaled corticosteroid as a reliever rather than as a controller of asthma symptoms.
Traffic-related air pollution may impact women more
Sep 20, 2022
The effects on plasma proteins known to play a role in inflammation, oxidative stress and cardiovascular disease are greater in women than in men.
Why comprehensive medication management is especially important now
By
Karmen L. Stephens, PharmD, BCGP
Mar 24, 2022
Comprehensive medication management, or CMM, is a whole-person approach to medication management that ensures that medications are appropriate, safe and effective, and that they support the individual’s...
Dry powder inhalers show benefits for asthma control, environment
Feb 08, 2022
Switching to a dry powder inhaler more than halves the carbon footprint of asthma treatment without asthma worsening.
FDA approves new drug to help control severe asthma
Dec 23, 2021
Tezspire is unique in that it only targets thymic stromal lymphopoietin, the molecule involved in airway inflammation.